Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Follicular × Aspirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 6 Recurrence 4 Prostatic Neoplasms 4 Neoplasms 3 Venous Thromboembolism 2 Rectal Neoplasms 2 Polycythemia Vera 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Cardiovascular Diseases 2 Adenoma 2 Vascular Diseases 1 Thrombosis 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Pathologic Processes 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Lymphoma, Follicular 1 Ischemic Stroke 1 Intestinal Neoplasms 1

Interventions

Rituximab 59 Cyclophosphamide 36 Vincristine 30 Prednisone 29 Doxorubicin 24 Lenalidomide 16 Radiotherapy 15 Bendamustine Hydrochloride 13 Etoposide 9 Peripheral Blood Stem Cell Transplantation 8 Filgrastim 8 tofacitinib 7 Prednisolone 7 obinutuzumab 6 VAP-cyclo protocol 6 Deoxycholic Acid 6 ibritumomab tiuxetan 5 fludarabine 5 Mitoxantrone 5 Methylprednisolone 5 Cytarabine 5 ibrutinib 4 fludarabine phosphate 4 R-CHOP protocol 4 Melphalan 4 Dexamethasone 4 Carmustine 4 tositumomab I-131 3 Radiation 3 Methotrexate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507645 2024-09-05

PUMICE

Beijing Tiantan Hospital

Phase 3 Completed

Ischemic Stroke, Lymphoma, Follicular, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡